Therefore, we quantified the levels of inflammatory factors in the 2 groups, finding that the levels of IL-1, IL-6, and TNF-α in the CG were significantly lower than those in the MG, which indicated that combined therapy could significantly relieve inflammation and promote the amelioration of xerophthalmia. The gene discussed is TNF; the disease is Keratoconjunctivitis sicca.